Fig. 1
From: A built-in adjuvant-engineered mucosal vaccine against dysbiotic periodontal diseases
Development of FlaB-LK1-tFomA (BtA) and Hgp44-LK3-FlaB (HB) fusion proteins for a divalent periodontal vaccine. a Characterization of a FlaB-LK1-tFomA fusion protein targeting F. nucleatum. Purified tFomA and FlaB-LK1-tFomA (BtA) were analyzed by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and western blot analysis with anti-tFomA, anti-FlaB, and anti-F. nucleatum (anti-Fn) serum. b Characterization of a Hgp44-LK3-FlaB fusion protein targeting P. gingivalis. Purified Hgp44 or Hgp44-LK3-FlaB (HB) were analyzed by SDS-PAGE and western blot analysis with anti-Hgp44, anti-FlaB, or anti-P. gingivalis (anti-Pg) serum
